Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
3 Biotechs And The Feuerstein-Ratain Rule
Seeking Alpha
A Look at Three Biotech Movers
Motley Fool
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Buy These 3 Cancer Stocks With Upcoming Catalysts
Seeking Alpha
Is Threshold on the Threshold of Something Big?
Motley Fool
What's Left For Threshold? Not Much
Seeking Alpha
3 Biotechs With Good FDA News
Motley Fool

